Literature DB >> 16801642

Neurosurgery in Parkinson disease: a distressed mind in a repaired body?

M Schüpbach1, M Gargiulo, M L Welter, L Mallet, C Béhar, J L Houeto, D Maltête, V Mesnage, Y Agid.   

Abstract

OBJECTIVE: To prospectively evaluate the impact of subthalamic nucleus (STN) stimulation on social adjustment in patients with Parkinson disease (PD).
METHODS: Before and 18 to 24 months after bilateral STN stimulation, the authors assessed 29 patients with PD for motor disability, cognition (Mattis dementia rating scale, frontal score), psychiatric morbidity (Mini-5.0.0, MADRS, BAS), quality of life (PDQ-39), social adjustment (Social Adjustment Scale), and psychological status using unstructured in-depth interviews.
RESULTS: Despite marked improvement in parkinsonian motor disability, the absence of significant changes in cognitive status, and improvement of activities of daily living and quality of life by the end of the study, social adjustment did not improve. Several kinds of problems with social adjustment were observed, affecting the patients' perception of themselves and their body, marital situation, and professional life. Marital conflicts occurred in 17/24 couples. Only 9 out of 16 patients who had a professional activity before the operation went back to work after surgery.
CONCLUSION: After STN stimulation, patients experienced difficulties in their relations with themselves, their spouses, their families, and their socio-professional environment. The authors suggest a multidisciplinary psychosocial preparation and follow-up to help patients and their entourage cope with the sudden changes in their existence following successful neurosurgery.

Entities:  

Mesh:

Year:  2006        PMID: 16801642     DOI: 10.1212/01.wnl.0000234880.51322.16

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  77 in total

1.  A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD.

Authors:  R J St George; J G Nutt; K J Burchiel; F B Horak
Journal:  Neurology       Date:  2010-10-05       Impact factor: 9.910

Review 2.  [Deep brain stimulation for Parkinson's disease].

Authors:  J Herzog; G Deuschl
Journal:  Nervenarzt       Date:  2010-06       Impact factor: 1.214

3.  Agency and intervention.

Authors:  Adina L Roskies
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

4.  Informed Consent in Implantable BCI Research: Identifying Risks and Exploring Meaning.

Authors:  Eran Klein
Journal:  Sci Eng Ethics       Date:  2015-10-23       Impact factor: 3.525

5.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

Review 6.  [New indications for deep brain stimulation: ethical criteria for research and therapy].

Authors:  M Synofzik
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

7.  Bilateral subthalamic stimulation impairs cognitive-motor performance in Parkinson's disease patients.

Authors:  Jay L Alberts; Claudia Voelcker-Rehage; Katie Hallahan; Megan Vitek; Rashi Bamzai; Jerrold L Vitek
Journal:  Brain       Date:  2008-10-07       Impact factor: 13.501

Review 8.  Deep brain stimulation for Parkinson's disease.

Authors:  Patricia Limousin; Irene Martinez-Torres
Journal:  Neurotherapeutics       Date:  2008-04       Impact factor: 7.620

9.  The Impact of Deep Brain Stimulation for Parkinson's Disease on Couple Satisfaction: An 18-Month Longitudinal Study.

Authors:  Marc Baertschi; Nicolas Favez; João Flores Alves Dos Santos; Michalina Radomska; François Herrmann; Pierre Burkhard; Alessandra Canuto; Kerstin Weber
Journal:  J Clin Psychol Med Settings       Date:  2019-12

Review 10.  Subthalamic deep brain stimulation and levodopa in Parkinson's disease: a meta-analysis of combined effects.

Authors:  Joaquin A Vizcarra; Miguel Situ-Kcomt; Carlo Alberto Artusi; Andrew P Duker; Leonardo Lopiano; Michael S Okun; Alberto J Espay; Aristide Merola
Journal:  J Neurol       Date:  2018-06-16       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.